#ESCCongress: BRACE CORONA Trial and Safety of Heart Drugs
Heart patients hospitalised with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor... Read more
#ESCCongress: No Link Between Blood Pressure Medication and Cancer
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the... Read more
#ESCCongress: EMPEROR-Reduced Trial Meets Primary Endpoint
In a Hot Line session today at ESC Congress 2020, findings from the EMPEROR-Reduced trial showed that empagiflozin reduces the risk of cardiovascular... Read more
Building a Blueprint to Implement VBHC at Operational Level
Digital Health Diplomacy in Chained Globalised Health Context
Charitable Institutions During the COVID-19 Pandemic: The Pisa Experience
Healthcare Workforce and Organisational Transformation with AI – Enacting Change
The World Health Organization (WHO) defines telemedicine as the delivery of health care services by healthcare professionals in areas where distance is a critical factor and where information and communication technologies need to be used for the exchange of information regarding diagnosis, treatment and prevention. The goal of telemedicine was... Read more
Prof. Mamas A Mamas is a structural interventional cardiologist, treating patients with underlying coronary artery with percutaneous coronary intervention (PCI) in both the elective and emergency setting and undertaking Transcatheter Aortic Valve Interventions (TAVI). He is also the Associate Editor of Circulation Cardiovascular Interventions and leads... Read more
Chelsea Beecher serves as the Director of Development for the American Heart & Stroke Association in New York City. She led the launch of STEM Goes Red in New York City and received the Innovator of the Year Award in 2018 for this initiative. STEM Goes Red aims to empower young women to pursue science, technology, engineering, and math (STEM)... Read more
The Post-ICU Patient - Management of Long-Term Impairments After Critical Illness
Survivors of critical illness and their caregivers frequently face long-term... Read more
Xenon limits brain damage following cardiac arrest
Xenon and brain injury. Xenon, a chemically inert but biologically... Read more
Management of bleeding in visceral surgery and liver transplantation
The implementation of patient blood management programmes led to reduced... Read more
New Image Sharing Technology Transforms Radiology Services Across Yorkshire
The XERO Exchange Network, a new image sharing technology from Agfa... Read more
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
Continuous non-invasive blood pressure, cardiac output and fluid management for moderate and low-risk surgery CNAP ® Monitor provides advanced hemodynamic information from the non-invasive resusable CNAP ® finger sensor . It supports your Goal...
CNAP® OEM partner solutions
The CNAP® technology is easily integrated into your product using our CNAP® OEM Partner Solutions.
INTEGRATION MADE EASY Discover our CNAP ® OEM partner solutions FULL SET OF NON-INVASIVE CONTINUOUS PATIENT SIGNALS Based on an easy-to-use dual finger sensor, the patented...
Hemodynamic measurement just got easier Task Force ® Touch CARDIO* provides a set of synchronized patient signals derived from the unique non-invasive CNAP ® finger sensor , combined with wireless 12-channel ECG. It is...